US$ 22.66
glutathione n-acetylcysteine pathway Chemical formula of and its conversion to N-Acetylcysteine and Its Immunomodulatory Properties
Description
CAS Number:137525-51-0

Drug development for nose-to-brain delivery for PD PD is the second most common neurodegenerative disease and the most common movement disorder worldwide, affecting more than 1% of the population over the age of 60 [149,150,151]

Where does CoLaz fit in

Studies suggest that supplements such as selenium, alpha-lipoic acid or N-Acetyl-Cysteine could significantly increase intracellular GSH levels
Its protective effects on healthy cells and tissues may improve the tolerability and effectiveness of chemotherapy

Yu, G., Wang, L.-G., Han, Y
